Visine A

Manufacturer: Johnson & Johnson Consumer Inc.
Effective date: 2016-03-24
Label type: HUMAN OTC DRUG LABEL
Version: 6
Source: legacy-cache
Hydrated at: 2026-08-02 01:27:46

Label at a glance#

ProductVisine A Multi-Action Eye Allergy Relief

Active ingredientNaphazoline Hydrochloride, Pheniramine Maleate

Label structure10 sections

Dosage and administration

adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to four times a day children under 6 years of age: consult a doctor

Storage and handling

some users may experience a brief tingling sensation store at 15° to 25°C (59° to 77°F)

Contacts and useful links#

PhoneLabel contact888-734-7648

PhoneLabel contact215-273-8755

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredients	Purpose
Naphazoline HCl 0.025%	Redness reliever
Pheniramine maleate 0.3%	Antihistamine

Use

INDICATIONS & USAGE SECTION

Temporarily relieves itchy, red eyes due to:

pollen
ragweed
grass
animal hair and dander

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use if you are sensitive to any ingredient in this product

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

heart disease
high blood pressure
narrow angle glaucoma
trouble urinating due to an enlarged prostate gland

When using this product

OTC - WHEN USING SECTION

pupils may become enlarged temporarily
do not touch tip of container to any surface to avoid contamination
replace cap after each use
remove contact lenses before using
do not use if this solution changes color or becomes cloudy
overuse may cause more eye redness

Stop use and ask a doctor if

OTC - STOP USE SECTION

you feel eye pain
changes in vision occur
redness or irritation of the eye lasts
condition worsens or lasts more than 72 hours

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Accidental swallowing by infants and children may lead to coma and marked reduction in body temperature.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to four times a day
children under 6 years of age: consult a doctor

Other information

STORAGE AND HANDLING SECTION

some users may experience a brief tingling sensation
store at 15° to 25°C (59° to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate, sodium hydroxide and/or hydrochloric acid

Questions?

OTC - QUESTIONS SECTION

call toll-free 888-734-7648 or 215-273-8755 (collect)

Caution

SPL UNCLASSIFIED SECTION

Do not use if VISINE^® imprinted neckband on bottle is broken or missing.

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Sterile
Visine_®-A_®
PHENIRAMINE MALEATE 0.3%
NAPHAZOLINE HYDROCHLORIDE 0.025%

ANTIHISTAMINE + REDNESS
RELIEVER EYE DROPS

MULTI-ACTION
EYE
ALLERGY
Relief

Clinically
proven to
relieve itchy,
red, allergy
eyes

1/2 FL OZ (15 mL)

PRINCIPAL DISPLAY PANEL - 15 mL Bottle Carton

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42002-200-05	ML - Milliliter	42002-200	a2034c97-1169-4d60-8761-b6bb536be54b	1	2017-07-07

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Naphazoline Hydrochloride	ACTIVE INGREDIENT	MZ1131787D	5
Pheniramine Maleate	ACTIVE INGREDIENT	NYW905655B	5
Naphazoline	ACTIVE MOIETY	H231GF11BV	5
Pheniramine	ACTIVE MOIETY	134FM9ZZ6M	5
Benzalkonium Chloride	INACTIVE INGREDIENT	F5UM2KM3W7	5
Boric Acid	INACTIVE INGREDIENT	R57ZHV85D4	5
Edetate Disodium	INACTIVE INGREDIENT	7FLD91C86K	5
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	5
Sodium Borate	INACTIVE INGREDIENT	91MBZ8H3QO	5
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	5
Water	INACTIVE INGREDIENT	059QF0KO0R	5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Visine A Multi-Action Eye Allergy Relief
Naphazoline Hydrochloride and Pheniramine Maleate
Naphazoline Hydrochloride
Naphazoline
Pheniramine Maleate
Pheniramine
Boric Acid
Sodium Borate
Benzalkonium Chloride
Edetate Disodium
Sodium Hydroxide
Hydrochloric Acid
Water

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
42002-200	42002-200-05, 42002-200-13

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Naphazoline Hydrochloride	MZ1131787D	ACTIB
Pheniramine Maleate	NYW905655B	ACTIB
Boric Acid	R57ZHV85D4	IACT
Sodium Borate	91MBZ8H3QO	IACT
Benzalkonium Chloride	F5UM2KM3W7	IACT
Edetate Disodium	7FLD91C86K	IACT
Sodium Hydroxide	55X04QC32I	IACT
Hydrochloric Acid	QTT17582CB	IACT
Water	059QF0KO0R	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 8 · 446 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	POWDER, FOR SOLUTION / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SYRUP / ORAL	2.03 mg/1ml		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SHAMPOO / TOPICAL		3 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	OINTMENT / TOPICAL		1 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / IRRIGATION	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	INJECTION / SOFT TISSUE	0.05 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	MOUTHWASH / BUCCAL	2 mg/1ml		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRACAUDAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	ENEMA / RECTAL	0.44 %v/v		Exact identifier — unii candidate 174 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	INJECTION, SUSPENSION / INTRAMUSCULAR		1 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	GEL / TOPICAL		10 mg	Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / SUBCUTANEOUS	1 %w/v		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAVITREAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INFILTRATION	0.37 %w/v		Exact identifier — unii candidate 148 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	INJECTION, SOLUTION / INTRAVENOUS		7 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	CAPSULE / ORAL	60 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAPERITONEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	JELLY / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / RECTAL	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	CONCENTRATE / ORAL	2.17 mg/1ml		Exact identifier — unii candidate 148 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SUSPENSION / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	POWDER, FOR SUSPENSION / ENDOTRACHEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR	5 mg		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INFILTRATION	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Boric Acid	BORIC ACID	R57ZHV85D4	EMULSION / TOPICAL	1.3 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRA-ARTERIAL		840 mg	Exact identifier — unii candidate 148 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION / ENDOTRACHEAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	LOTION / TOPICAL		22 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	FILM, SOLUBLE / BUCCAL		5 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	4.17 mg		Exact identifier — unii candidate 148 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / RESPIRATORY (INHALATION)	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / RETROBULBAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SUSPENSION/ DROPS / AURICULAR (OTIC)	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	LIQUID / NASAL	2 mg/1ml		Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / NASAL	20 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAMUSCULAR		78 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	EMULSION / OPHTHALMIC	0.3 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	TABLET / ORAL	2.32 mg		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Borate	SODIUM BORATE	91MBZ8H3QO	SOLUTION / AURICULAR (OTIC)	0.3 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SOLUTION/ DROPS / OPHTHALMIC	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	SYSTEM / TOPICAL		126 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	SPRAY / NASAL		1 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRA-ARTERIAL	176 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAMUSCULAR	176 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 148 equally ranked IID candidates
Boric Acid	BORIC ACID	R57ZHV85D4	SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC	0.3 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / INTRAOCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Boric Acid	BORIC ACID	R57ZHV85D4	MOUTHWASH / BUCCAL	7.36 mg/1ml		Exact identifier — unii candidate 17 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / SUBCUTANEOUS	31.45 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	SUSPENSION / RESPIRATORY (INHALATION)	0.01 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	CONCENTRATE / ORAL	10 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020485-001	VISINE	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC		RLD, RS	1996-01-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020485-001	VISINE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	RLD, RS	1996-01-31	`3a93d1ddd44b…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
db1f7543-bc7b-4383-b2dc-a25db8b8a5a2			82500e4c-bc01-4ce0-80d8-6e9f0be99163	2016-03-24	Warnings	Exact identifier spl id: db1f7543-bc7b-4383-b2dc-a25db8b8a5a2 spl set id: 82500e4c-bc01-4ce0-80d8-6e9f0be99163

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.